Fig. 1 · Structure
Documents & Downloads
TFCP2L1-IN-1
TFCP2L1 Inhibitor
TFCP2L1-IN-1 is a selective inhibitor of the TFCP2L1 protein, demonstrating significant anti-cancer activity. It enhances apoptosis and diminishes cell proliferation, invasion, and metastasis in hepatocellular carcinoma cells, especially when used in combination with Sorafenib. This compound is valuable for research focused on cancer treatment and understanding the role of TFCP2L1 in tumor biology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 364621-46-5 |
| Applications | TFCP2L1 Inhibitor |
| Formula | C15H13BrN2OS |
| Molecular Weight | 349.25 |
| SMILES | BrC1=CC=CC(C(NC(NC2=CC=CC=C2C)=S)=O)=C1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.